FR2422406A1 - Composition comprenant un concentrat de particules de dane - Google Patents

Composition comprenant un concentrat de particules de dane

Info

Publication number
FR2422406A1
FR2422406A1 FR7910456A FR7910456A FR2422406A1 FR 2422406 A1 FR2422406 A1 FR 2422406A1 FR 7910456 A FR7910456 A FR 7910456A FR 7910456 A FR7910456 A FR 7910456A FR 2422406 A1 FR2422406 A1 FR 2422406A1
Authority
FR
France
Prior art keywords
composition
concentrate
dane particles
dane
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7910456A
Other languages
English (en)
Other versions
FR2422406B1 (fr
Inventor
William J Mcaleer
Edward H Wasmuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/784,191 external-priority patent/US4129646A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2422406A1 publication Critical patent/FR2422406A1/fr
Application granted granted Critical
Publication of FR2422406B1 publication Critical patent/FR2422406B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D43/00—Separating particles from liquids, or liquids from solids, otherwise than by sedimentation or filtration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

La présente invention concerne une composition comprenant un concentrat de particules de Dane. Il s'agit d'une composition comprenant un concentrat de particules de Dane dans un milieu synthétique physiologiquement acceptable Cette composition est utile pour la préparation d'agents immunologiques.
FR7910456A 1976-11-02 1979-04-25 Composition comprenant un concentrat de particules de dane Granted FR2422406A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73786276A 1976-11-02 1976-11-02
US05/784,191 US4129646A (en) 1976-11-02 1977-04-04 Isolating hepatitis B Dane particles

Publications (2)

Publication Number Publication Date
FR2422406A1 true FR2422406A1 (fr) 1979-11-09
FR2422406B1 FR2422406B1 (fr) 1982-11-19

Family

ID=27113269

Family Applications (3)

Application Number Title Priority Date Filing Date
FR7732653A Granted FR2394297A1 (fr) 1976-11-02 1977-10-28 Particules de dane de l'hepatite b
FR7910455A Granted FR2422399A1 (fr) 1976-11-02 1979-04-25 Procede pour la concentration de particules de dane par fractionnement isopycnique
FR7910456A Granted FR2422406A1 (fr) 1976-11-02 1979-04-25 Composition comprenant un concentrat de particules de dane

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR7732653A Granted FR2394297A1 (fr) 1976-11-02 1977-10-28 Particules de dane de l'hepatite b
FR7910455A Granted FR2422399A1 (fr) 1976-11-02 1979-04-25 Procede pour la concentration de particules de dane par fractionnement isopycnique

Country Status (5)

Country Link
JP (1) JPS5379011A (fr)
DE (1) DE2748520A1 (fr)
FR (3) FR2394297A1 (fr)
GB (2) GB1554400A (fr)
NL (1) NL7711378A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
DK366778A (da) * 1978-08-18 1980-02-19 Foss Electric As Fremgangsmaade til taelling af bakterier
DE3049690A1 (de) * 1979-07-05 1982-02-18 Alpha Therapeutic Corp Process for producing hepatitis b vaccine
DE3150935A1 (de) * 1981-12-23 1983-06-30 Uwe Dr.med. 3400 Göttingen Böttcher Verfahren zur herstellung eines hepatitis-b impfstoffes
EP0114291A3 (fr) * 1983-01-24 1985-12-04 Bodo Dr. Plewinsky Milieu pour la séparation de matières dissoutes et/ou en suspension en fonction de leurs flottabilités ou de leurs densités différentes, au moyen de solutions de métatungstates purs
FR2561256B1 (fr) * 1984-03-16 1987-01-02 Pasteur Institut Procede de purification de particules biologiques de type antigene hbs, par ultracentrifugation de flottation sur gradient de densite

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2152800A1 (fr) * 1971-09-09 1973-04-27 Pfizer
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen
FR2382238A1 (fr) * 1977-02-23 1978-09-29 Merck & Co Inc Procede de purification de l'antigene de l'hepatite b, et produits obtenus
FR2412315A1 (fr) * 1977-02-23 1979-07-20 Merck & Co Inc Procede de preparation d'un antigene de l'hepatite b et l'antigene obtenu

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2152800A1 (fr) * 1971-09-09 1973-04-27 Pfizer
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen
FR2382238A1 (fr) * 1977-02-23 1978-09-29 Merck & Co Inc Procede de purification de l'antigene de l'hepatite b, et produits obtenus
FR2412315A1 (fr) * 1977-02-23 1979-07-20 Merck & Co Inc Procede de preparation d'un antigene de l'hepatite b et l'antigene obtenu

Also Published As

Publication number Publication date
JPS5379011A (en) 1978-07-13
DE2748520C2 (fr) 1987-07-30
FR2422406B1 (fr) 1982-11-19
GB1554400A (en) 1979-10-17
FR2422399B1 (fr) 1982-11-19
GB1554399A (en) 1979-10-17
FR2422399A1 (fr) 1979-11-09
DE2748520A1 (de) 1978-05-03
NL7711378A (nl) 1978-05-05
JPS635381B2 (fr) 1988-02-03
FR2394297A1 (fr) 1979-01-12
FR2394297B1 (fr) 1982-11-19

Similar Documents

Publication Publication Date Title
FR2354316A1 (fr) Nouveaux agents de contraste iodes non-ioniques
FR2397659A1 (fr) Particules electrosensibles utilisables pour former des images par migration electrophoretique
FR2599046B1 (fr) Compositions nettoyantes liquides en microemulsion
DK0587555T3 (da) Biofunktionel ligand af DTPA-type
FR2371449A1 (fr) Acide 1-carba-2-penem-3-carboxylique
FR2384789A1 (fr) Fixation de proteines a des particules inertes
FR2377376A1 (fr) Derives d'hexahydroterphenyle et leur application en tant que cristaux liquides
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
FR2442884A1 (fr) Compositions detersives pour soins d'hygiene ou de toilette, dont le composant actif est une phosphobetaine ou une phosphitaine
ATE26115T1 (de) Substituierte 8-phenylxanthine.
FR2333244A1 (fr) Determination serologique de la presence d'anticorps anti-neisseria gonorrhoeae
ES8603558A1 (es) Procedimiento de preparacion de suspensiones liquidas nacaradas de agente tensoactivo cationico-alcohol superior-alfa-mono (alquil ramificado, con metil glicerial eter)
ES8505650A1 (es) Un metodo de producir una emulsion grasa que contiene ester alquilico de prostaglandina e1
FR2375218A1 (fr) 2-imidazoline-5-ones a substitution chirale
FR2388346A1 (fr) Determination de parametres d'une fonction d'autocorrelation
FR2443282A1 (fr) Procedes et composition catalytiques d'hydroformylation et d'hydrohydroxymethylation
FR2457295A1 (fr) Composes intermediaires pour la preparation de cephalosporines
FR2422406A1 (fr) Composition comprenant un concentrat de particules de dane
DK0474712T3 (da) Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
FR2426035A1 (fr) Composes de metaux de transition hexacoordonnes contenant au moins un substituant polyfluoroalcoyle et combustibles les contenant
SE8201213L (sv) Detergentkompositioner
DK638088D0 (da) Substituerede dicarboxylsyre-bis(3,5-dicarbamoyl-2,4,6-trijodanilider), fremgangsmaade til fremstilling deraf samt roentgenkontrastmidler indeholdende disse
BE847391A (fr) Attache pour la fixation demontable de la pointe de dent d'une dent d'excavateur,
FR2346052A1 (fr) Centrifugeuse pour l'elimination d'agents liquides adherant a des copeaux ou corps semblables
FR2430937A1 (fr) Triiodo-benzonitriles et agents de diagnostic qui en contiennent

Legal Events

Date Code Title Description
ST Notification of lapse